• Drugs and Devices

    The Drugs and Devices Committee is actively engaged with the FDA and other scientific, governmental, clinical, and industry representatives to provide neurosurgical expertise on drugs, devices, and biologics used to treat patients, and to foster innovation and patient safety. These activities include recommending neurosurgeon experts to serve on the FDA Advisory panels, providing input on FDA Guidance Documents, and testimony at panel meetings, as appropriate. In addition, organized neurosurgery is an official partner with the FDA’s Network of Experts program to provide rapid clinical assistance to FDA reviewers. The CNS continues to advocate policies that will decrease the regulatory burden for medical device innovation and ensure patient access to new and improved medical technology.

    Key Resource Links:

    View Archives

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site here. Privacy Policy